NEDL1, more commonly referred to as NEDD4L, is an E3 ubiquitin-protein ligase which plays a pivotal role in diverse cellular functions by regulating the ubiquitination and subsequent degradation of target proteins. NEDD4L contributes to the process of protein homeostasis, an essential aspect of cellular health and function. Disruptions to this balance can lead to a host of cellular abnormalities, which may culminate in disease states.
Activators of NEDD4L are compounds that enhance or stimulate the ubiquitination activity of NEDD4L. These could potentially operate by increasing the expression of NEDD4L, enhancing its ligase activity, or promoting its interaction with its target proteins. Given the broad range of proteins that NEDD4L can ubiquitinate, the effects of such activators would likely be highly context-dependent, varying based on the specific cellular environment and the presence of other signaling molecules. The precise ways in which these activators might interact with NEDD4L and the consequences of these interactions would be a rich area for scientific exploration. Understanding these interactions could provide valuable insights into the complex web of protein interactions that underpin cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Through the activation of the PI3K-Akt-mTOR pathway, insulin may enhance or stimulate the activity of NEDD4L. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, as a PI3K inhibitor, could potentially escalate the activity of NEDD4L by modulating the PI3K-Akt-mTOR pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 can potentially boost the activity of NEDD4L by altering the PI3K-Akt-mTOR pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin may enhance the activity of NEDD4L by causing changes in the mTOR pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 can potentially stimulate NEDD4L activity through its effects on the MAPK/ERK pathway. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 could potentially amplify NEDD4L activity by modulating the TGF-β/SMAD pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 could potentially boost NEDD4L activity by altering JNK signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 could potentially escalate the activity of NEDD4L by modulating NF-κB signaling. | ||||||